# Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT

> **NCT00586274** · PHASE1 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 1 (actual)

## Conditions studied

- FANCONI ANEMIA

## Interventions

- **PROCEDURE:** CD34 selected haploidentical PBSCT
- **DRUG:** Fludarabine
- **BIOLOGICAL:** T cell infusion
- **BIOLOGICAL:** Campath 1h
- **BIOLOGICAL:** anti-CD45

## Key facts

- **NCT ID:** NCT00586274
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-03
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2014-03-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586274, "Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00586274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*